NEW YORK (Reuters) - With the broad S & P 500 Index gliding once again into uncharted territory and posting four straight weeks of gains, the talk of Wall Street's rally inevitably hitting a ceiling is starting to get old.
Stephen Barnes: Amgen ( AMGN ) shares (up over 22% year-to-date) have had an impressive run this year, outpacing the S & P 500 by about 6%. Nevertheless, despite outpacing the broader market, Amgen has only matched the Health Care Sector Select Sector
NEW YORK, May 17 (Reuters) - With the broad S & P 500 Index gliding once again into uncharted territory and posting four straight weeks of gains, the talk of Wall Street's rally inevitably hitting a ceiling is starting to get old.
impressive gains from here," the bank says. In particular, a slowdown would affect two of the most impressive markets the most; the S & P 500 and the Nikkei, which have risen more than 16% and 46% this year, respectively. Post your comment!
* Dow up 0.8 percent, S & P 500 up 1 percent, Nasdaq up 1 percent
* Dow up 0.8 percent, S & P 500 up 1 percent, Nasdaq up 1 percent
* Dow up 0.8 percent, S & P 500 up 1 percent, Nasdaq up 1 percent
* Fed's Williams says stimulus reduction could start this summer * U.S. consumer sentiment rises to nearly six-year high * U.S. dollar index hits nearly three-year high * Dow, S & P 500 surge to record...
eye on Dean Foods ( DF +1% ). Though the food company could see some choppy trading next week after it was dumped from the S & P 500 , dealReporter notes there's plenty of M&A speculation around the name to keep shares perky. A market cap below $4B raises
* Dow up 0.5 percent, S & P 500 up 0.7 percent, Nasdaq up 0.6 percent